Evaluation of the Use of the GenXpert to Detect Hepatitis C RNA

Hasselt University

Status: Unknown

Conditions: Hepatitis C; Drug Use

Treatments: Other: screening: HCV RNA test and risk factors questionaire

Study type: Interventional

Funder types: Other

Identifiers

NCT04717856

CEPHEID-01

Details and patient eligibility

About

The results of the GX device are equivalent to standard venous blood sampling. With this study we are going to determine the prevalence in drug users with difficult venous access. On the other hand, we want to look at the place this device can have in primary care.

Enrollment: 300 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Have recently or ever used drugs
• Older than 18 years
• Written informed consent

Exclusion criteria

• Not being able to speak the Dutch language

Trial design

Primary purpose: Screening

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

300 participants in 1 patient group

drug users

Other group

Treatment:

Other: screening: HCV RNA test and risk factors questionaire